Cytek Biosciences, Inc. (CTKB) Stock Moves -0.33%: What You Should Know

Yahoo FinanceMay 1 05:45

Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024

FREMONT, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced it will report financial results for the first

Cytek BiosciencesApr 29 12:00

Cytek Biosciences(CTKB.US) Officer Sells US$117.4K in Common Stock

$Cytek Biosciences(CTKB.US)$ Officer Yan Ming sold 20,000 shares of common stock on Apr 19, 2024 at an average price of $5.87 for a total value of $117.4K.Source: Announcement What is statement of cha

Futu NewsApr 24 06:49

Cytek Biosciences(CTKB.US) Officer Sells US$13,304 in Common Stock

$Cytek Biosciences(CTKB.US)$ Officer Yan Ming sold 1,900 shares of common stock on Apr 9, 2024 at an average price of $7 for a total value of $13,304.Source: Announcement What is statement of changes

Futu NewsApr 12 06:59

Form 144 | Cytek Biosciences(CTKB.US) Officer Proposes to Sell 268K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 9, $Cytek Biosciences(CTKB.US)$ Officer MING YAN intends to sell 40,000 shares of its common stock on Apr 9, with a total market value of approximately $268K. MING YAN ha

Futu NewsApr 10 04:28

Optimistic Outlook: Cytek Biosciences Poised for Growth With New CFO Appointment

TipRanksMar 22 05:05